Professional Documents
Culture Documents
Drexel Finance and Investment Group; Weekly View of February 25, 2013 manufacturing companies in the industrials sector. A stock to watch is Document Security Systems (NYSE: DSS), a developer and producer of technologies focused on fraud and forgery prevention. Recently, the firm has been testing an authentication application for digital devices such as iPhones. As the use of mobile phones for important business becomes more prevalent, the demand for such software will increase. The stock, trading around $2.50 a share, rose by nearly 10% Friday. VVUS was big in the news last year with the launch of a new weight loss drug. Weight loss drugs seem like a great investment in the current situation of US society. But, VIVUS as an upcoming future star failed to be one of the pioneering forces in the weight loss drug market. The sales figure for Qsymia was half of the reduced estimate. And to top that, estimates are that they are going to suffer with their new erectile dysfunction drug too. Stendra was approved by FDA just last year and it is going up against competitors like Viagra from Pfeizer (PFE), Levitra by Bayer (BAX) and GlaxoSmithKline (GSK). Then there is also Cialis from Lilly (LLY). Last week, VVUS lost 18.45% of its value on the back of disastrous Qsymia sales; and the outlook seems grim. One of the rising stars of pharmaceuticals in the last year lost all their growth from last year. It just shows once again that Pharmaceuticals is still a player in large cap field. Even if a mid or small gains momentum, they are falling of the train badly.
Pharmaceuticals, controlled by big caps The volatile market edged a little up by the end of the volatile week. The healthcare industry, which has been moving along the same line as the market in recent times, was actually down by the end of the week. S&P Healthcare Services Select is down by almost 0.7% while Pharmaceuticals are down by 0.3%. One of the biggest disappointments of the week was VIVUS (VVUS).
Drexel Finance and Investment Group; Weekly View of February 25, 2013 The week of March 04, 2013 As a new month starts, we should see a lot of economic data coming in. But, it is likely that Italian situation will still hold a large portion of market moving news. The question is whether they have to go into a new election; or will a grand coalition be formed? Whatever happens, it is likely to be messy. The non-manufacturing ISM report will come out Tuesday; it will show us the situation of the larger portion of US economy. We will have the Fed Beige book on Wednesday and see which portion of the country is driving growth and who are the ones suffering. Weekly jobless claims report will come out on Thursday; the forecast shows a rise in claims. US productivity report for the last quarter is due on March 7th. It should be interesting to see where US stands on one of the biggest growth drivers. There is also a report on household debt for fourth quarter due the same day. This has been the developing indicator that will pave the way for future consumption. Another big indicator due to come out is the manufacturing payroll for February. Due on Friday, it will show growth activity and possibilities in manufacturing. The unemployment rate is also due to be published on Friday.
Contributors: Insurances are ready for a comeback Vincent Laudicina Heavy machinery sales point to growth Jeffrey Herr Pharmaceuticals, controlled by big caps Tafhimul Huda
Director: Maureen Gribb Editor: Tafhimul Huda Assistant Editor: Phillip Nabedrik